Rep. Guthrie voted yes on 100% of bills classified as favoring Pharmaceuticals & Biotech, Telecommunications, and Technology—his top donor sectors—ranking #27 highest among House members on this metric. He voted yes on HR3537-117, classified as favoring Pharmaceuticals & Biotech, which accelerated access to critical therapies for ALS, and also voted yes on 5 of 6 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
S3451-117 — A bill to include certain computer-related projects in the Federal permitting program under title XL
FOLLOW THE TRAIL
◈ Ask the Analyst about Brett Guthrie →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated September 7, 2026 · internal signal score 94/100.